|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1986-3-14
|
|
pubmed:abstractText |
Four patients with progressive extensive chronic graft-versus-host disease or dose-limiting toxicity on conventional therapy (cyclophosphamide + prednisolone) were treated with a regimen of cyclosporine + prednisolone as induction therapy and cyclosporine as maintenance therapy. All 4 showed clinical improvement and 3 of 4 are alive at 9 months. The incidence of infections was not affected by this regimen, but steroid requirements were reduced.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
170-2
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:3511579-Acute Disease,
pubmed-meshheading:3511579-Adult,
pubmed-meshheading:3511579-Anemia, Aplastic,
pubmed-meshheading:3511579-Bone Marrow Transplantation,
pubmed-meshheading:3511579-Chronic Disease,
pubmed-meshheading:3511579-Cyclophosphamide,
pubmed-meshheading:3511579-Cyclosporins,
pubmed-meshheading:3511579-Drug Therapy, Combination,
pubmed-meshheading:3511579-Graft vs Host Disease,
pubmed-meshheading:3511579-Humans,
pubmed-meshheading:3511579-Leukemia,
pubmed-meshheading:3511579-Male
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Cyclosporine as an alternative to cyclophosphamide in the treatment of chronic graft-versus-host disease.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
